Development of cardioplegia for newborn cardiac surgery.
新生儿心脏手术心脏停跳液的开发。
基本信息
- 批准号:15390408
- 负责人:
- 金额:$ 2.37万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To elucidate the role of anaerobic glycolysis durnig ischemia for the genesis of subsequentreperfusion injury in neonatal hearts, we investigated the effects of glucose and deoxyglucose(DG) on isolated neborn(2-5 days) rabbit hearts perfused in vitro. Following cardiac arrest induced by St. Thomas' Hospital cardioplegic solution(ST), the hearts were subjected to hypothermic ischemia for 180 min. Glucose(5mM) or DG(5mM) was added to ST. Percentage recovery of left ventricular developed pressure(LVDP) after 30 min reperfusion, lactate/pyruvate ratio(L/P) in the coronary effluent during the first minute of reperfusion and CK leakage were as follows(^*p<0.05 vs ST, ANOVA) :%rec LVDP L/P ratio CK leakageST 72.7+3.3 23.3+1.2 41.5+13.0ST+glucose 58.9+3.9^* 36.9+4.4^* 40.0+5.3ST+DG 96.3+1.4^* 17.3+3.8^* 18.9+4.5^*Addition of glucose resulted in a decrease in % rec of LVDP and an increase in L/P, an index of redox state. DG application caused a significant increase in % rec of LVDP and a decrease in L/P as well as in CK leakage. These results suggested that anaerobic glycolysis during in neonatal hearts during ischemia mya set a stage for larger Ca overload with Na+/H+ and Na+/Ca2+ exchange, leading to greater myocardioal injury. potential usefulness of DG in cardioplegia was proposed.
为探讨缺血缺氧性糖酵解在新生兔心脏再灌注损伤中的作用,本实验观察了葡萄糖和脱氧葡萄糖(DG)对新生兔离体心脏缺血再灌注损伤的影响。托马斯医院心脏停搏液(ST)诱导心脏停搏后,低温缺血180分钟,ST中加入葡萄糖(5mM)或DG(5mM),再灌注30分钟后左室发展压(LVDP)恢复百分比,再灌注第1分钟冠脉流出液中的乳酸/丙酮酸比值(L/P)和CK渗漏如下(^* p <0.05 vs ST,ANOVA):% rec LVDP L/P比率CK渗漏ST 72.7 + 3.3 23.3 + 1.2 41.5 + 13.0 ST+葡萄糖58.9 + 3.9 ^* 36.9 + 4.4 ^* 40.0 + 5.3ST + DG 96.3 + 1.4 ^* 17.3 + 3.8 ^* 18.9 + 4.5 ^* 添加葡萄糖导致LVDP % rec降低和L/P增加,L/P是氧化还原状态的指数。DG的应用导致了LVDP的% rec的显着增加和L/P以及CK泄漏的下降。结果提示,缺血心肌无氧糖酵解为心肌细胞Na +/H+和Na +/Ca~(2+)交换造成更大的钙超载,导致心肌损伤。提出DG在心脏停搏液中的潜在用途。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
UEDA Yuuichi其他文献
UEDA Yuuichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
AI enhanced lifetime-based mesoscopic in vivo imaging of tissue molecular heterogeneity
人工智能增强了基于寿命的组织分子异质性细观体内成像
- 批准号:
10585510 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Intestinal Stem Cell Metabolism in Inflammatory Bowel Disease Mucosal Healing
炎症性肠病粘膜愈合中的肠道干细胞代谢
- 批准号:
10606371 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Imaging cerebral metabolic impairment in AD using Deuterium MRI
使用氘 MRI 对 AD 中的脑代谢损伤进行成像
- 批准号:
10608908 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Validation of imaging brain tumor metabolism using deuterated glucose
使用氘化葡萄糖验证脑肿瘤代谢成像
- 批准号:
10560260 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Development of Anorexigenic and Glucoregulatory Chimeric Peptides
厌食和血糖调节嵌合肽的开发
- 批准号:
10735323 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.
建立组件的工业化生产,使癌症患者群体能够更容易地获得 PET 成像。
- 批准号:
10698218 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Brain glucose deficiency: mechanisms and modulation
脑葡萄糖缺乏:机制和调节
- 批准号:
10730183 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Quantifying the Brain Metabolism Underlying Task-Based BOLD Imaging
量化基于任务的 BOLD 成像背后的大脑代谢
- 批准号:
10432379 - 财政年份:2022
- 资助金额:
$ 2.37万 - 项目类别:
Metabolic imaging of hyperpolarized 13C pyruvate in polycystic kidney disease
多囊肾病中超极化 13C 丙酮酸的代谢成像
- 批准号:
10527162 - 财政年份:2022
- 资助金额:
$ 2.37万 - 项目类别: